Mark J. Calcott

772 total citations
13 papers, 532 citations indexed

About

Mark J. Calcott is a scholar working on Molecular Biology, Pharmacology and Microbiology. According to data from OpenAlex, Mark J. Calcott has authored 13 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Pharmacology and 3 papers in Microbiology. Recurrent topics in Mark J. Calcott's work include Microbial Natural Products and Biosynthesis (7 papers), Chemical Synthesis and Analysis (6 papers) and Antimicrobial Peptides and Activities (3 papers). Mark J. Calcott is often cited by papers focused on Microbial Natural Products and Biosynthesis (7 papers), Chemical Synthesis and Analysis (6 papers) and Antimicrobial Peptides and Activities (3 papers). Mark J. Calcott collaborates with scholars based in New Zealand, Australia and United Kingdom. Mark J. Calcott's co-authors include David F. Ackerley, Jeremy G. Owen, Robert A. Keyzers, Allison Knight, Iain L. Lamont, Gregory L. Challis, Elsie M. Williams, Rory F. Little, Chanel J. Taylor and Wayne A. Schroder and has published in prestigious journals such as Chemical Society Reviews, Nature Communications and Applied and Environmental Microbiology.

In The Last Decade

Mark J. Calcott

13 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark J. Calcott New Zealand	10	328	297	121	107	55	13	532
Soohyun Um South Korea	11	293 0.9×	292 1.0×	54 0.4×	64 0.6×	156 2.8×	33	653
Eva Mösker Germany	12	298 0.9×	240 0.8×	25 0.2×	66 0.6×	51 0.9×	18	511
Frank Wesche Germany	7	335 1.0×	287 1.0×	25 0.2×	42 0.4×	65 1.2×	13	450
Torsten Neuhof Germany	14	274 0.8×	307 1.0×	62 0.5×	213 2.0×	92 1.7×	20	600
Julia Penn United Kingdom	12	421 1.3×	446 1.5×	53 0.4×	74 0.7×	133 2.4×	16	663
Matthias Schiell Germany	10	212 0.6×	148 0.5×	27 0.2×	51 0.5×	48 0.9×	15	383
Marley Yeong Netherlands	3	417 1.3×	354 1.2×	38 0.3×	90 0.8×	116 2.1×	4	606
Marc Röttig Germany	6	428 1.3×	359 1.2×	17 0.1×	72 0.7×	111 2.0×	7	607
Claudio Greco United States	16	219 0.7×	263 0.9×	36 0.3×	197 1.8×	71 1.3×	21	492
Daniel Krahn Germany	11	449 1.4×	117 0.4×	41 0.3×	322 3.0×	31 0.6×	18	607

Countries citing papers authored by Mark J. Calcott

Since Specialization

Citations

This map shows the geographic impact of Mark J. Calcott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Calcott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Calcott more than expected).

Fields of papers citing papers by Mark J. Calcott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Calcott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Calcott. The network helps show where Mark J. Calcott may publish in the future.

Co-authorship network of co-authors of Mark J. Calcott

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Calcott. A scholar is included among the top collaborators of Mark J. Calcott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Calcott. Mark J. Calcott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Owen, Jeremy G., et al.. (2023). Metagenomic domain substitution for the high-throughput modification of nonribosomal peptides. Nature Chemical Biology. 20(2). 251–260. 14 indexed citations

Schroder, Wayne A., Mark J. Calcott, Elke Kaemmerer, et al.. (2023). Cyclotheonellazoles D-I, Potent Elastase Inhibitory Thiazole-Containing Cyclic Peptides from Theonella sp. (2131). Journal of Natural Products. 86(9). 2216–2227. 8 indexed citations

Taylor, Chanel J., et al.. (2023). A Genomic Survey of the Natural Product Biosynthetic Potential of Actinomycetes Isolated from New Zealand Lichens. mSystems. 8(2). e0103022–e0103022. 4 indexed citations

Ackerley, David F., et al.. (2020). High-Throughput Screening for Inhibitors of the SARS-CoV-2 Protease Using a FRET-Biosensor. Molecules. 25(20). 4666–4666. 32 indexed citations

Calcott, Mark J., Jeremy G. Owen, & David F. Ackerley. (2020). Efficient rational modification of non-ribosomal peptides by adenylation domain substitution. Nature Communications. 11(1). 4554–4554. 71 indexed citations

Calcott, Mark J., et al.. (2020). The indigoidine synthetase BpsA provides a colorimetric ATP assay that can be adapted to quantify the substrate preferences of other NRPS enzymes. Biotechnology Letters. 42(12). 2665–2671. 8 indexed citations

Williams, Elsie M., Mark J. Calcott, Janine N. Copp, et al.. (2020). Intracellular complexities of acquiring a new enzymatic function revealed by mass-randomisation of active-site residues. eLife. 9. 9 indexed citations

Calcott, Mark J., et al.. (2018). Structural, functional and evolutionary perspectives on effective re-engineering of non-ribosomal peptide synthetase assembly lines. Natural Product Reports. 35(11). 1210–1228. 75 indexed citations

Calcott, Mark J., David F. Ackerley, Allison Knight, Robert A. Keyzers, & Jeremy G. Owen. (2017). Secondary metabolism in the lichen symbiosis. Chemical Society Reviews. 47(5). 1730–1760. 159 indexed citations

10.

Owen, Jeremy G., et al.. (2016). Generating Functional Recombinant NRPS Enzymes in the Laboratory Setting via Peptidyl Carrier Protein Engineering. Cell chemical biology. 23(11). 1395–1406. 32 indexed citations

11.

Calcott, Mark J. & David F. Ackerley. (2015). Portability of the thiolation domain in recombinant pyoverdine non-ribosomal peptide synthetases. BMC Microbiology. 15(1). 162–162. 21 indexed citations

12.

Calcott, Mark J. & David F. Ackerley. (2014). Genetic manipulation of non-ribosomal peptide synthetases to generate novel bioactive peptide products. Biotechnology Letters. 36(12). 2407–2416. 42 indexed citations

13.

Calcott, Mark J., Jeremy G. Owen, Iain L. Lamont, & David F. Ackerley. (2014). Biosynthesis of Novel Pyoverdines by Domain Substitution in a Nonribosomal Peptide Synthetase of Pseudomonas aeruginosa. Applied and Environmental Microbiology. 80(18). 5723–5731. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact